Clinical Trials Directory

Trials / Completed

CompletedNCT00258115

The Study of Inflammation on Blood Glucose Levels in Obese People

The Study of Inhibition of Inflammation in the Dysmetabolic Syndrome of Obesity

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Joslin Diabetes Center · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Chronic subaccute inflammation may underlie the development of diabetes cardiovascular disease and other components of the metabolic syndrome. Rodent studies suggest diet induced obesity is associated with activation of the IKK/NF-kB pathway and this pathway can be inhibited by salicylates. This study seeks to determine the effect of salicylates in overweight persons.

Conditions

Interventions

TypeNameDescription
DRUGsalsalate

Timeline

Start date
2003-12-01
Primary completion
2007-10-01
First posted
2005-11-24
Last updated
2018-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00258115. Inclusion in this directory is not an endorsement.